Managing Diabetes with Gliclazide SR (60mg) and Metformin SR (500mg)...

GLICLAGLAZE MET 

gliclazide SR (60mg),Metformin SR (500 mg)

GLICLAGLAZE MET emerges as a cornerstone in the treatment of type 2 diabetes mellitus, offering the combined therapeutic benefits of Gliclazide SR and Metformin SR. This powerful combination of medications provides comprehensive glycemic control and helps individuals better manage their diabetes. In this comprehensive guide, we delve into the mechanisms of action, therapeutic efficacy, dosage considerations, potential side effects, and essential precautions associated with GLICLAGLAZE MET, providing valuable insights for patients and healthcare professionals alike.

Understanding Gliclazide SR and Metformin SR: GLICLAGLAZE MET combines two widely used antidiabetic agents: Gliclazide SR and Metformin SR. Gliclazide SR is a sulfonylurea medication that stimulates insulin secretion from the pancreas, while Metformin SR is a biguanide that reduces glucose production in the liver and improves insulin sensitivity in peripheral tissues.

Mechanism of Action: Gliclazide SR enhances insulin secretion from pancreatic beta cells, promoting glucose uptake by tissues and lowering blood sugar levels. Metformin SR reduces hepatic glucose production and enhances peripheral glucose utilization, thereby improving insulin sensitivity and reducing overall blood sugar levels. The combined action of these medications helps achieve better glycemic control in individuals with type 2 diabetes.

Therapeutic Efficacy: Clinical studies have demonstrated the efficacy of GLICLAGLAZE MET in lowering HbA1c levels and improving overall glycemic control in patients with type 2 diabetes mellitus. By targeting multiple pathways involved in glucose metabolism, this combination medication offers superior efficacy compared to monotherapy with either agent alone.

Dosage Considerations: The dosage of GLICLAGLAZE MET may vary depending on individual patient characteristics, glycemic control goals, and tolerability. It is typically taken orally once or twice daily with meals. Healthcare providers may initiate treatment with a lower dose and adjust it gradually based on blood sugar levels and response to therapy.

Potential Side Effects: While generally well-tolerated, GLICLAGLAZE MET may cause side effects such as gastrointestinal upset (e.g., nausea, diarrhea), hypoglycemia (low blood sugar), or weight gain. Rarely, more serious adverse reactions such as lactic acidosis or allergic reactions may occur. Patients should be aware of these potential side effects and seek medical attention if they occur.

Precautions and Safety Measures: Before starting GLICLAGLAZE MET therapy, healthcare providers should assess patients for contraindications, including renal impairment, hepatic dysfunction, or hypersensitivity to sulfonylureas or biguanides. Regular monitoring of renal function, liver enzymes, and blood glucose levels is recommended during treatment to ensure the safety and efficacy of therapy.

Conclusion: GLICLAGLAZE MET offers a comprehensive approach to managing type 2 diabetes mellitus, harnessing the synergistic effects of Gliclazide SR and Metformin SR. By addressing both insulin secretion and insulin sensitivity, this combination medication provides individuals with diabetes a powerful tool to achieve better glycemic control and improve overall health outcomes. Through collaborative efforts between patients and healthcare providers, GLICLAGLAZE MET continues to play a pivotal role in the management of diabetes, empowering individuals to lead healthier and more fulfilling lives.  Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW